Time dependent changes in the individual domains of the SGRQ. Results of the TORCH trial

P. Jones, P. Calverley, B. Celli, J. Anderson, G. Ferguson, C. Jenkins, J. Yates, J. Vestbo (London, Liverpool, Greenford, Manchester, United Kingdom; Boston, MA, Livonia, MI, RTP, NC, United States Of America; Sydney, Australia)

Source: Annual Congress 2007 - New insights into the treatment of COPD
Session: New insights into the treatment of COPD
Session type: Thematic Poster Session
Number: 3583
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Jones, P. Calverley, B. Celli, J. Anderson, G. Ferguson, C. Jenkins, J. Yates, J. Vestbo (London, Liverpool, Greenford, Manchester, United Kingdom; Boston, MA, Livonia, MI, RTP, NC, United States Of America; Sydney, Australia). Time dependent changes in the individual domains of the SGRQ. Results of the TORCH trial. Eur Respir J 2007; 30: Suppl. 51, 3583

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Determinants of the relationship between changes in FEV1 and SGRQ: analysis of the TORCH data
Source: Annual Congress 2008 - COPD
Year: 2008


Improving morning activities in COPD patients with budesonide/formoterol: Assessment of data from two randomised trials using minimal important differences from a morning activities questionnaire
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010

Predicting SGRQ score based on CAT score: post-hoc analysis of the IMPACT trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Comparison of individual items of COPD Assessment Test (CAT) at baseline in the EMAX and IMPACT trials
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020


Breath Holding Time in uncontrolled Asthma: associations with key physiological tests and patient-reported outcome measures
Source: International Congress 2019 – Exercise and physiotherapy in patients with asthma, cystic fibrosis, bronchiectasis and primary ciliary dyskinesia
Year: 2019


Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Correlations between SGRQ and other clinical and functional parameters in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 809s
Year: 2006

Changes in quality of life as assessed by St. Georges respiratory questionnaire (SGRQ) and COPD assessment test (CAT) and spirometric indices in patients with smoker-COPD(S-COPD) and non-smoker-COPD(NS-COPD) after 1 year of follow up
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014


Comparison of outcomes of the Actigraph and the Dynaport activity monitor in patients with COPD; results from PROactive
Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation
Year: 2012


Do changes in spirometric indices and FeNO predict asthma outcomes in children? An individual patient data analysis using results from seven FeNO trials
Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Year: 2018



Relationship between exacerbation frequency and quality of life using the airways questionnaire 20 (AQ20) in a randomised controlled trial
Source: Eur Respir J 2005; 26: Suppl. 49, 715s
Year: 2005

Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study
Source: Eur Respir J 2004; 24: Suppl. 48, 240s
Year: 2004

Characterization of exercise impairment in relation to quality of life (QoL) and hospital admission in COPD patients; data from the INTERCOM trial
Source: Eur Respir J 2005; 26: Suppl. 49, 433s
Year: 2005

COPD exacerbations significantly impact quality of life as measured by SGRQ-C total score: results from the FLAME study
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017




COPD eDiary compliance: Comparison of age, symptom score, duration in clinical trial and country of origin
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Assessing asthma control using a composite measure based on GINA/NIH guidelines: an analysis of GOAL baseline data
Source: Eur Respir J 2002; 20: Suppl. 38, 47s
Year: 2002

Determining SGRQ and TDI responder rates across the duration of clinical trials: Results from tiotropium + olodaterol in COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017


Quality of life in patients with COPD. Results of EPIDEPOC study
Source: Eur Respir J 2005; 26: Suppl. 49, 718s
Year: 2005

Patients‘ perception of their own influence on asthma (locus of control). Results from an observational study
Source: Eur Respir J 2007; 30: Suppl. 51, 147s
Year: 2007